This IP boutique remains a market leader for patent disputes in the Netherlands. It will be hard for competitors to launch a real challenge to this position any time soon, especially since Brinkhof has lately been extremely visible in the courts for clients such as Oppo concerning mobile communications and Boston Scientific and Sandoz in the life science sector.
The market-leading Dutch patent team of this international IP boutique remains the benchmark to which other Dutch – and indeed European – firms can aspire. The team benefits from an impressive list of high-profile clients, as well as no less than ten highly regarded litigation partners. It also has an abundance of in-house patent attorneys, which often appear alongside their litigation colleagues in highly complex and technical cases. This is especially to the benefit of clients such as Hanwha Q-Cells, which have recently been head-to-head at t...
After several years of growth, the Dutch offering of this integrated international firm is in an ideal position to begin challenging the patent market leaders for the top spot. Last year, Bird & Bird concentrated on expanding its presence from The Hague into the Dutch capital, and now several leading patent partners are poised to provide support for an expanding client base of generic drug companies and telecommunication technology clients. As ever, Bird & Bird's relationship with Nokia remains hugely important for the practice's overall develo...Full Analysis
The Dutch office of international firm Freshfields Bruckhaus Deringer continues to pursue the market leaders, as impressive new instructions and retention of major clients lead to increasing visibility in the patent market. This is especially true for pharmaceutical and life sciences companies, with this year’s headline instruction coming from Moderna. Highly-visible and recommended partner Rutger Kleemans is coordinating the company’s litigation against BioNTech and Pfizer in multiple locations, including in Germany, regarding Covid-19 vaccine...Full Analysis
With a strong presence, especially in life sciences cases, Hogan Lovells’ Amsterdam patent team remains an important challenger to the two firms at the top of the Dutch litigation market. The team has been highly active for originator drug manufacturers such as MSD and Bristol-Meyers Squibb, and has very close ties to Eli Lilly – even if the dispute over pemetrexed ended in 2021. The patent team is also involved in one of the most extensive medical products cases in Europe thanks to its work for Meril Life Sciences.Full Analysis
The patent litigation team at this international full-service firm can look back at another successful year at the Dutch patent courts. The team around figurehead Bas Berghuis was once again highly visible at the patent court in The Hague for Bayer Healthcare and Serenity Pharma, ensuring the team remains one of the most significant challengers to the two market leaders Brinkhof and Hoyng ROKH Monegier.Full Analysis
The patent litigation team of the Dutch full-service firm continues to be an extremely visible presence in the Dutch patent market with an impressive client list, successfully capitalising on the expertise from across its various internal departments to strengthen its IP offering. For example, on the telecommunication side, lawyers from the firm’s M&A and transactional practices have been involved alongside the patent team in litigating for clients, including Sharp in a campaign against Oppo. With highly-visible and recommended partner Gert...Full Analysis
Thanks to extensive activity for manufacturers of generic drugs and biosimilars, Vondst is currently one of the most active litigation firms at the Dutch patent courts. Especially for Teva and Sandoz, the partners were very active in disputes against BSM, Bayer and Novartis and other originator drugs companies regarding important original drugs and SPCs. Otto Swens, Ricardo Dijkstra and Arvid van Oorschot have a good reputation for litigation in pharma cases.Full Analysis
The patent litigation team of this national full-service firm is well positioned in the Dutch patent market. The team is mainly known for assisting generic drug companies such as Stada and Insud in disputes over pharmaceutical and biosimilar drugs. Recently the team played a prominent role in defending core client Mylan against a preliminary injunction from Novartis concerning the multiple sclerosis drug fingolimod. It fought at the side of other generics manufacturers in the Netherlands and other European jurisdictions.Full Analysis
The well-positioned patent litigation team of this Dutch full-service firm is known in the Netherlands for pharmaceutical disputes. But in the past twelve months, it has again showcased its broad technical setup better than ever before, even if its clout in mobile communications cases is not what it was in former years. Wiko is currently the firm’s only client in this sector, with the team representing it in a court case.Full Analysis
Over the past twelve months, Taylor Wessing's well-positioned patent practice has overcome several changes at partner level to remain visible and recommended in the Dutch market. It was dealt a blow earlier in 2022 when the firm’s head of patents Judith Krens departed, along with two associates, to help build up Pinsent Masons’ life sciences offering in Amsterdam. Clearly, losing its foremost life sciences partner could have been disastrous for a firm so strongly associated with the sector. But in Eindhoven, the office’s capabilities were bolst...Full Analysis
While remaining one of the Netherlands' smaller patent litigation practices, with just one partner heading up the Allen & Overyoffering, the firm nevertheless continues to be well-positioned in the Dutch market. It has a solid list of clients, especially in the life sciences sector, and over the past few years, Frits Gerritzen has appeared in some high-profile disputes. On the telecommunication side, this includes Dutch client KPN which, alongside Nokia, continues to field a FRAND defence against opponent Assia. However, it is mostly thanks...Full Analysis
The well-positioned Dutch patent practice of DLA Piper continues to retain a small and steady stream of clients from a variety of sectors. While it has historically proven its clout in electronics or engineering cases, the past few years have heightened the team’s visibility in the biotechnology sector. This shows for example its retention of clients such as Scenic Biotech in a case involving patents for immuno-oncology. The patent practice also continues with its multi-jurisdictional advisory work for Sakata over plant variety infringement; in...Full Analysis
The selection of law firms in the above table reflects the research of the editorial staff at JUVE and is based on interviews with clients, lawyers and academics. It remains a subjective view and implies no disparagement of any firm not mentioned here but which is nevertheless active in this field. The firms are alphabetically listed within the groups. To find out more about our rankings and research criteria please click here and here.